CONVERTIBLE PROMISSORY NOTES AND SHORT TERM LOANS (Details Narrative) - USD ($) |
1 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 02, 2024 |
Jan. 09, 2024 |
Dec. 08, 2023 |
Oct. 25, 2023 |
Aug. 11, 2023 |
Jul. 18, 2023 |
Jul. 13, 2023 |
Mar. 29, 2023 |
Jan. 23, 2023 |
Dec. 30, 2022 |
Dec. 21, 2021 |
Mar. 31, 2024 |
Feb. 29, 2024 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Dec. 31, 2022 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Mar. 31, 2021 |
Oct. 23, 2023 |
Sep. 25, 2023 |
Nov. 30, 2022 |
|
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest expense | $ 1,005,005 | $ 159,602 | |||||||||||||||||||||
Issuance of debt | $ 11,756,563 | ||||||||||||||||||||||
Debt conversion description | The redemption price was determined in accordance to the Series B note agreement, where the Company has an option to redeem the note at 115% of its principal value instead of converting the note upon receipt of a conversion notice. The difference between the redemption cash payment and the book value of the note redeemed, including the derivative liability associated to the note | ||||||||||||||||||||||
Deferred finance costs | $ 193,437 | ||||||||||||||||||||||
Debt converted amount | 2,962,386 | $ 2,355,318 | |||||||||||||||||||||
Debt face amount | $ 12,400,000 | $ 364,000 | |||||||||||||||||||||
Adjustment for amortization | 49,393 | ||||||||||||||||||||||
Interest expense | $ 3,018,803 | 1,839,159 | |||||||||||||||||||||
Warrants issued | 57,536 | 57,536 | |||||||||||||||||||||
Convertible note issuances | $ 4,103 | ||||||||||||||||||||||
Redemption of convertible notes | 135,710 | 126,680 | |||||||||||||||||||||
Gains losses on extinguishment of debt | 18,539 | (71,119) | |||||||||||||||||||||
Derivative liabilities non current | $ 1,435,668 | 1,435,668 | 759,065 | ||||||||||||||||||||
Convertible notes payable | 221,396 | ||||||||||||||||||||||
Gross proceeds | 853,030 | 1,476,121 | |||||||||||||||||||||
Maturity date | Dec. 21, 2026 | ||||||||||||||||||||||
Debt instrument interest and debt expense | 263,696 | ||||||||||||||||||||||
Finance charge | 50,000 | ||||||||||||||||||||||
Accrued interest | 795,656 | 795,656 | 239,614 | ||||||||||||||||||||
Line of Credit Facility, Revolving Credit Conversion to Term Loan, Description | In assigning the selling accounts receivables to the revolving loan lender, the Company is receiving 85% of their value as an advance of its regular collection of those receivables | ||||||||||||||||||||||
Financing Receivable, Revolving, Converted to Term Loan | $ 1,200,000 | ||||||||||||||||||||||
Line of Credit Facility, Capacity Available for Trade Purchases | 125,000 | $ 300,000 | 125,000 | ||||||||||||||||||||
Increase (Decrease) in Accounts Receivable | 1,286,792 | 298,248 | (686,197) | ||||||||||||||||||||
Line of Credit Facility, Annual Principal Payment | 1,411,792 | ||||||||||||||||||||||
Revolving Credit Facility [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Accrued interest | 23,879 | 23,879 | |||||||||||||||||||||
Eighteen Month Anniversary [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest rate | 12.00% | ||||||||||||||||||||||
Debt converted amount | $ 250,000 | ||||||||||||||||||||||
Debt face amount | $ 1,000,000 | ||||||||||||||||||||||
Twenty Four Month Anniversary [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest rate | 8.00% | ||||||||||||||||||||||
Debt converted amount | $ 114,303 | ||||||||||||||||||||||
Other Convertible Notes Payable [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest rate | 10.00% | ||||||||||||||||||||||
Convertible notes payable | $ 2,000,000 | ||||||||||||||||||||||
Convertible notes payable | 45,045 | ||||||||||||||||||||||
Convertible notes payable | $ 221,621 | ||||||||||||||||||||||
Notes Payable, Other Payables [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Unamortized issuance cost discount | 186,404 | ||||||||||||||||||||||
Adjustment for amortization | 186,404 | 35,217 | |||||||||||||||||||||
Series A Preferred Stock [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Convertible notes payable | 821,500 | 821,500 | |||||||||||||||||||||
Convertible notes payable remaining | 821,500 | $ 821,500 | 200,000 | ||||||||||||||||||||
Series B Preferred Stock [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt conversion description | Holders may elect to convert shares of Series B Preferred Stock to common stock at an alternate conversion price equal to 80% (or 70% if the Company’s common stock is suspended from trading on or delisted from a principal trading market or if the Company has effected a reverse split of the common stock) of the lowest daily volume weighed average price of the common stock during the Alternate Conversion Measuring Period (as defined in the Certificate of Designations). In the event the Company receives a conversion notice that elects an alternate conversion price, the Company may, at its option, elect to satisfy its obligation under such conversion with payment in cash in an amount equal to 110% of the conversion amount. | ||||||||||||||||||||||
Convertible notes payable | 157,720 | $ 157,720 | |||||||||||||||||||||
Convertible notes payable remaining | 22,010 | 22,010 | 157,720 | ||||||||||||||||||||
Series A Convertible Note Holders [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Warrants issued | 51,101 | ||||||||||||||||||||||
Warrant [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Warrants issued | 51,101 | 51,101 | |||||||||||||||||||||
Warrant [Member] | Placement Agent [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 12% of funds raised for $8,925,550 (face value) of the notes (first series) and 2.5% of funds raised for the remaining $2,350,000 (face value) of notes (second series), with an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing. On final closing, which occurred on January 8, 2021, the warrants’ exercise price was struck at $6.36 per share. | ||||||||||||||||||||||
Preferred Stock [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest rate | 15.00% | ||||||||||||||||||||||
Interest expense | 74,851 | ||||||||||||||||||||||
Convertible notes payable | |||||||||||||||||||||||
Two Series A Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Issuance of debt | $ 11,275,500 | ||||||||||||||||||||||
Interest rate | 12.00% | ||||||||||||||||||||||
Two Series A Notes [Member] | Warrant [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. The warrants have a 3-year term from date of issuance and an exercise price that is 120% of the 20-day volume weighted average price of the Company’s common shares at the time final closing | ||||||||||||||||||||||
Series A Notes One [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Description of conversion terms for debt instrument | (i) the Outstanding Balance divided by (ii) 75% of the volume weighted average price of the Common Stock for the 5 trading days prior to the Conversion Date (the conversion price). | ||||||||||||||||||||||
Debt conversion description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion, redeem the notes for 115% of their face value plus accrued interest. | ||||||||||||||||||||||
Series A Notes One [Member] | Placement Agent [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was obligated to pay the placement agent of the first series of Series A Notes a 12% cash fee for $8,925,500 (face value) of the notes and 2.5% cash fee and other sundry expenses for the remaining $2,350,000 (face value) of the notes | ||||||||||||||||||||||
Series A Notes Two [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt conversion description | the notes would automatically convert into common stock (in each case, subject to the trading volume of the Company’s common stock being a minimum of $500,000 for each trading day in the 20 consecutive trading days immediately preceding the conversion date), upon the earlier to occur of (i) the Company’s common stock being listed on a national securities exchange, in which event the conversion price would be equal to the lower of $24.00 per share or 75% of the volume weighted average price of the common stock for the 20 trading days prior to the conversion date, or (ii) upon the closing of the Company’s next equity round of financing for gross proceeds of greater than $5,000,000, in which event the conversion price would be equal to the lower of $24.00 per share or 75% of the price per share of the common stock (or of the conversion price in the event of the sale of securities convertible into common stock) sold in such financing. The Company could, at its discretion, redeem the notes for 115% of their face value plus accrued interest | ||||||||||||||||||||||
Conversion price | $ 24.00 | ||||||||||||||||||||||
Volume weighted average price of common stock, percent | 75.00% | ||||||||||||||||||||||
Series A Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 2,301,854 | ||||||||||||||||||||||
Unamortized issuance cost discount | 8,088,003 | ||||||||||||||||||||||
Debt converted amount | 10,575,500 | ||||||||||||||||||||||
Debt face amount | 700,000 | ||||||||||||||||||||||
Series A Notes [Member] | Additional Collateralized Bridge Loan Agreement [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 28,000 | ||||||||||||||||||||||
Series A Note [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | $ 500,000 | ||||||||||||||||||||||
Accrued interest | 173,762 | 173,762 | 74,912 | ||||||||||||||||||||
Interest expense | 98,850 | 100,556 | |||||||||||||||||||||
New Convertible Note [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Interest rate | 12.00% | ||||||||||||||||||||||
Debt instrument carrying amount | $ 621,500 | ||||||||||||||||||||||
Debt instrument accrued interest | $ 121,500 | ||||||||||||||||||||||
Debt instrument interest rate during period | 75.00% | ||||||||||||||||||||||
Series B Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt conversion description | The Series B Notes will automatically convert into common stock upon a merger, consolidation, exchange of shares, recapitalization, reorganization, as a result of which the Company’s common stock shall be changed into another class or classes of stock of the Company or another entity, or in the case of the sale of all or substantially all of the assets of the Company other than a complete liquidation of the Company. Within the first 180 days after the issuance date, the Company may, at its discretion, redeem the notes for 115% of their face value plus accrued interest. The Company is obligated to issue warrants that accompany the convertible notes and provide 50% warrant coverage. | ||||||||||||||||||||||
Deferred finance costs | 10,000 | ||||||||||||||||||||||
Unamortized issuance cost discount | 1,312,500 | ||||||||||||||||||||||
Debt converted amount | $ 555,600 | 472,500 | |||||||||||||||||||||
Debt face amount | 45,681 | 45,681 | $ 840,000 | ||||||||||||||||||||
Convertible note issuances | $ 1,240,000 | ||||||||||||||||||||||
Converted instrument shares issued | 126,833 | 34,586 | |||||||||||||||||||||
Debt instrument periodic payment | $ 126,680 | ||||||||||||||||||||||
Cash payment | $ 145,682 | ||||||||||||||||||||||
Convertible notes payable | 24,408 | ||||||||||||||||||||||
Series B Notes [Member] | Accredited Investors [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt face amount | $ 1,312,500 | ||||||||||||||||||||||
Series B Notes [Member] | Warrant [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Warrants and Rights Outstanding, Term | 3 years | ||||||||||||||||||||||
Series B Notes [Member] | Warrant One [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 6.36 | ||||||||||||||||||||||
Warrants issued | 100,000 | ||||||||||||||||||||||
Series B Notes [Member] | Warrant Two [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 9.0 | ||||||||||||||||||||||
Warrants issued | 35,417 | ||||||||||||||||||||||
Series B Note [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Accrued interest | $ 88,602 | 88,602 | 84,863 | ||||||||||||||||||||
Interest expense | 3,739 | 7,886 | |||||||||||||||||||||
Redemption of convertible notes | 135,710 | ||||||||||||||||||||||
Payment redeemed cash | 162,851 | ||||||||||||||||||||||
Gains losses on extinguishment of debt | 18,540 | ||||||||||||||||||||||
Series C Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Issuance of debt | $ 1,812,700 | ||||||||||||||||||||||
Interest rate | 15.00% | 15.00% | |||||||||||||||||||||
Description of conversion terms for debt instrument | (i) seventy-five percent (75%) of the VWAP for the five (5) Trading Days prior to the Conversion Date, or (ii) eighty percent (80%) of the gross sale price per share of Common Stock (or conversion or exercise price per share of Common Stock of any Common Stock Equivalents) sold in a Qualified Financing | ||||||||||||||||||||||
Debt conversion description | the notes would convert into common stock at the applicable “Mandatory Conversion Price”, if either (i) on each of any twenty (20) consecutive Trading Days (the “Measurement Period”) (A) the closing price of the Common Stock on the applicable Trading Market is at least $18.00 per share and (B) the dollar value of average daily trades of the Common Stock on the applicable Trading Market is at least $400,000 per Trading Day; or (ii) upon the closing of a Qualified Financing, provided that the dollar value of average daily trades of the Common Stock on the applicable National Exchange on each of the ten (10) consecutive Trading Days following such closing is at least $400,000 per Trading Day. Mandatory Conversion Price means, in the case of a Mandatory Conversion under situation (i) above, seventy percent (70%) of the VWAP over the Measurement Period, or in the case of a Mandatory Conversion under situation (ii) above, eighty percent (80%) of the gross sale price per share of Common Stock (or conversion or exercise price per share of Common Stock of any Common Stock Equivalents) sold in a Qualified Financing | ||||||||||||||||||||||
Unamortized issuance cost discount | $ 1,232,274 | $ 1,232,274 | 578,589 | ||||||||||||||||||||
Debt face amount | 590,000 | ||||||||||||||||||||||
Adjustment for amortization | 693,518 | 195,828 | |||||||||||||||||||||
Convertible note issuances | 1,100,430 | ||||||||||||||||||||||
Derivative liabilities non current | 1,278,786 | 1,278,786 | |||||||||||||||||||||
Debt issuance costs | 207,361 | ||||||||||||||||||||||
Debt instrument derivative liabilities | 1,005,829 | ||||||||||||||||||||||
Accretion expense | $ 134,013 | 184,417 | |||||||||||||||||||||
Series C Notes [Member] | Note Holders [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 4.18 | ||||||||||||||||||||||
Series C Notes [Member] | Placement Agents Warrants [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 2.09 | ||||||||||||||||||||||
Series C Notes [Member] | Placement Agent [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was obligated to pay the placement agent of the first series of Series C Notes a 10% cash fee for the face value of the notes | ||||||||||||||||||||||
Series C Notes [Member] | Warrant [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was obligated to issue warrants that accompany the convertible notes and provide 100% warrant coverage. The warrants have a 4-year term from date of issuance and an exercise price that is 200% of the 5-day volume weighted average price of the Company’s common shares at the time of final closing | ||||||||||||||||||||||
Series C Notes [Member] | Warrant [Member] | Placement Agent [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Placement agent fees description | The Company was also obligated to issue warrants to the placement agent that have a 10-year term and cover 8% of face value of the notes, with an exercise price that equals to the 5-day volume weighted average price of the Company’s common shares at the time final closing. | ||||||||||||||||||||||
Series C Note [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Accrued interest | 253,643 | $ 253,643 | 2,598 | ||||||||||||||||||||
Interest expense | 251,045 | 2,598 | |||||||||||||||||||||
Short-term Bridge Loan Agreement [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Adjustment for amortization | 6,142 | 3,857 | |||||||||||||||||||||
Accretion expense | 66,213 | 93,787 | |||||||||||||||||||||
Repayments of loan | 341,675 | ||||||||||||||||||||||
Short-term Bridge Loan Agreement [Member] | Collateralized Merchant Finance Company [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 15,750 | $ 24,000 | $ 9,999 | 9,999 | |||||||||||||||||||
Debt instrument carrying amount | 844,200 | 540,000 | 560,000 | 560,000 | |||||||||||||||||||
Adjustment for amortization | 24,000 | ||||||||||||||||||||||
Debt instrument periodic payment | 19,195 | 38,705 | 13,995 | ||||||||||||||||||||
Accretion expense | 141,870 | ||||||||||||||||||||||
Gross proceeds | $ 630,000 | $ 400,000 | $ 400,000 | ||||||||||||||||||||
Debt instrument term | 308 days | 98 days | 280 days | ||||||||||||||||||||
Repayments of loan | 158,129 | ||||||||||||||||||||||
Short-term Bridge Loan Agreement [Member] | Finance Company [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | $ 443,185 | ||||||||||||||||||||||
Short-term Bridge Loan Agreement [Member] | Additional Collateralized Bridge Loan Agreement [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Gross proceeds | 700,000 | ||||||||||||||||||||||
Short-term Bridge Loan Agreement [Member] | Collateralized Merchant Finance Company One [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 35,000 | ||||||||||||||||||||||
Unamortized issuance cost discount | 26,879 | 26,879 | |||||||||||||||||||||
Debt instrument carrying amount | 1,008,000 | 581,105 | 581,105 | ||||||||||||||||||||
Adjustment for amortization | 8,121 | ||||||||||||||||||||||
Debt instrument periodic payment | 29,235 | ||||||||||||||||||||||
Accretion expense | 114,985 | ||||||||||||||||||||||
Gross proceeds | $ 700,000 | ||||||||||||||||||||||
Debt instrument term | 245 days | ||||||||||||||||||||||
Repayments of loan | 204,645 | ||||||||||||||||||||||
Short-term Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 32,000 | 32,000 | |||||||||||||||||||||
Debt instrument carrying amount | 1,120,000 | 1,120,000 | |||||||||||||||||||||
Adjustment for amortization | 20,800 | 11,200 | |||||||||||||||||||||
Debt instrument periodic payment | 29,556 | ||||||||||||||||||||||
Accretion expense | 148,027 | 171,973 | |||||||||||||||||||||
Gross proceeds | 800,000 | ||||||||||||||||||||||
Repayments of loan | 768,445 | ||||||||||||||||||||||
Short-term Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | First Four Weeks [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument periodic payment | 13,999 | ||||||||||||||||||||||
Promissory Note Agreement [Member] | Individual Investor [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | 600,000 | $ 600,000 | $ 600,000 | 600,000 | 600,000 | ||||||||||||||||||
Debt instrument interest rate during period | 25.00% | ||||||||||||||||||||||
Interest expense | 150,411 | 43,562 | |||||||||||||||||||||
Maturity date | Dec. 15, 2023 | ||||||||||||||||||||||
Early payment penalty provision percentage | 3.00% | ||||||||||||||||||||||
Debt instrument interest and debt expense | 12,723 | 12,312 | |||||||||||||||||||||
Promissory Note Agreement [Member] | Individual Investor One [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | 660,504 | $ 660,504 | 660,504 | ||||||||||||||||||||
Debt instrument interest rate during period | 12.00% | ||||||||||||||||||||||
Interest expense | 7,131 | ||||||||||||||||||||||
Debt instrument interest and debt expense | 7,101 | ||||||||||||||||||||||
New Promissory Note [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Unamortized issuance cost discount | |||||||||||||||||||||||
Debt instrument carrying amount | 270,000 | 270,000 | |||||||||||||||||||||
Debt face amount | $ 270,000 | ||||||||||||||||||||||
Adjustment for amortization | 7,304 | 29,460 | |||||||||||||||||||||
Maturity date | Dec. 31, 2023 | ||||||||||||||||||||||
Debt instrument, fair value disclosure | $ 248,479 | ||||||||||||||||||||||
Adjustment carrying value and principal amount | $ 21,521 | ||||||||||||||||||||||
Accrued interest | 50,000 | 50,000 | |||||||||||||||||||||
Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Deferred finance costs | $ 12,000 | ||||||||||||||||||||||
Debt instrument carrying amount | 420,000 | ||||||||||||||||||||||
Gross proceeds | 300,000 | ||||||||||||||||||||||
Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | First Four Weeks [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument periodic payment | 5,250 | ||||||||||||||||||||||
Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | Remaining Thirty Six Weeks [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument periodic payment | $ 11,083 | ||||||||||||||||||||||
Additional Collateralized Bridge Loan Agreement [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Adjustment for amortization | 5,727 | ||||||||||||||||||||||
Accretion expense | 120,305 | ||||||||||||||||||||||
Repayments of loan | 249,535 | ||||||||||||||||||||||
Additional Collateralized Bridge Loan Agreement [Member] | Finance Company [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Unamortized issuance cost discount | $ 10,023 | 2,800 | 2,800 | ||||||||||||||||||||
Debt instrument carrying amount | 980,000 | 93,848 | 93,848 | ||||||||||||||||||||
Adjustment for amortization | 29,700 | ||||||||||||||||||||||
Debt instrument periodic payment | 24,500 | ||||||||||||||||||||||
Accretion expense | 344,187 | ||||||||||||||||||||||
Repayments of loan | 543,083 | ||||||||||||||||||||||
Loss on amendment of debt | $ 59,161 | ||||||||||||||||||||||
Loans and Promissory Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Repayments of loan | $ 1,476,121 | ||||||||||||||||||||||
Two Short Term Promissory Notes [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | 427,500 | 427,500 | |||||||||||||||||||||
Debt face amount | $ 250,000 | 250,000 | 250,000 | ||||||||||||||||||||
Accrued interest | $ 75,000 | 75,000 | |||||||||||||||||||||
Administrative fees | 75,000 | ||||||||||||||||||||||
Administrative fees | 25,000 | ||||||||||||||||||||||
Administrative fees | $ 50,000 | ||||||||||||||||||||||
Two Short Term Promissory Notes [Member] | One Investor [Member] | |||||||||||||||||||||||
Short-Term Debt [Line Items] | |||||||||||||||||||||||
Debt instrument carrying amount | $ 500,000 |